Nicotine causes changes in brain nicotinic acetylcholine receptors (nAChRs) during smoking that initiate addiction. Nicotine-induced upregulation is the long-lasting increase in nAChR radioligand binding sites in brain resulting from exposure. The mechanisms causing upregulation are not established. Many different mechanisms have been reported with the assumption that there is a single underlying cause. Using live rat cortical neurons, we examined for the first time how exposure and withdrawal of nicotine shape the kinetics of native ␣4␤2-containing nAChR upregulation in real time. Upregulation kinetics demonstrates that at least two different mechanisms underlie this phenomenon. First, a transient upregulation occurs that rapidly reverses, faster than nAChR degradation, and corresponds to nAChR conformational changes as assayed by conformational-dependent, subunit-specific antibodies. Second, a long-lasting process occurs correlating with increases in nAChR numbers caused by decreased proteasomal subunit degradation. Previous radioligand binding measurements to brain tissue have measured the second process and largely missed the first. We conclude that nicotine-induced upregulation is composed of multiple processes occurring at different rates with different underlying causes.
Introduction
Nicotine is the major addiction-causing component in tobacco. Addiction is initiated by nicotine binding to high-affinity sites on nicotinic acetylcholine receptors (nAChRs) in brain. nAChRs are membrane proteins belonging to the cys-loop family of neurotransmitter-gated ion channels (Karlin and Akabas, 1995; Albuquerque et al., 2009) . Neuronal nAChRs are comprised of eight different ␣ subunits: ␣2-␣7; ␣9 -␣10; and three other ␤ subunits, ␤2-␤4. Different nAChR subtypes are pentamers composed of two or more different ␣ and ␤ subunits, with the exception of the ␣-bungarotoxin-binding subtype, which only contains ␣7 subunits (Drisdel and Green, 2000) , resulting in distinct pharmacology and function in vivo (Sargent, 1993; McGehee and Role, 1995) . The majority of high-affinity nicotinebinding sites in brain contain ␣4 and ␤2 subunits (Whiting and Lindstrom, 1988) . In addition, there are other less characterized subtypes including receptors composed of ␣4, ␤2, and ␣5 subunits (Conroy and Berg, 1998) ; ␣3, ␤2, and ␤4 subunits (Xu et al., 1999; Parker et al., 2004) ; and ␣6 with other subunits (Klink et al., 2001; Cui et al., 2003; Parker et al., 2004) .
Nicotine-induced upregulation is linked to different processes in nicotine addiction, including sensitization (Vezina et al., 2007; Govind et al., 2009 ) and withdrawal (De Biasi and Dani, 2011) . Upregulation occurs when nicotine exposure increases highaffinity nicotine-binding sites in brain, measured by radiolabeled agonists such as nicotine (Marks et al., 1983; Schwartz and Kellar, 1983; Benwell et al., 1988; Breese et al., 1997) or epibatidine (Perry et al., 1999) . Several factors limit studies examining the mechanisms underlying upregulation. First, the number of brain nAChR subtypes is not known because of their low levels. Another limitation is that radioligand binding to brain nAChRs is performed on membrane preparations or autoradiography sections, and events that occur in live neurons may be missed. An alternative approach has been heterologous expression of different subunit combinations in mammalian cell lines or Xenopus oocytes (Peng et al., 1994; Hsu et al., 1996; Fenster et al., 1999) . The disadvantage of heterologous expression is that nAChR subunit composition, while defined, may not correspond to that of native nAChRs. Non-neuronal cells may also lack brain-specific factors that regulate upregulation in brain.
Here, we assayed nicotine-induced upregulation of native nAChRs using live cortical neurons, which allowed real-time measurements of nAChR upregulation. We examined the initiation of upregulation and its reversal with nicotine withdrawal. The kinetics of native nAChR upregulation is biphasic revealing different processes that cause nicotine-induced upregulation. The first process is rapid and did not correlate with changes in the number of nAChRs, but did correlate with conformationaldependent binding of antibodies (Abs) . The data are consistent with nAChR conformational changes causing transitions between a resting low-affinity state and an upregulated high-affinity state, as previously proposed (Vallejo et al., 2005) . The second process is much slower and correlated with slowed ␤2 subunit endoplasmic reticulum (ER) degradation, which causes increased subunit assembly and increased insertion of cell-surface S-labeled lysates were incubated with anti-HA polyclonal antibody, mAb270 (␤2), AChR ␤2 C-20 (␤2), mAb 299 (␣4), or 6963 (␣4) overnight at 4°C. Antibody-antigen complexes were precipitated with protein G-Sepharose (GE Healthcare), and purified subunits were analyzed on a 4 -8% gradient with SDS-PAGE. The gel was dried and exposed to Bio-Rad screen, and the auto-rad was developed using a Bio-Rad molecular imager pharos-FX (Bio-Rad). Quantification was done using ImageJ.
Nicotine-induced upregulation and 125 I-epibatidine binding. HEK cells stably expressing ␣4␤2HA maintained at 37°C in DMEM were treated with 10 M nicotine for 17 h. For intact counts, cells were washed three times with PBS and collected by gentle agitation with PBS followed by incubation with 5 nM 125 I-epibatadine ( 125 I-epi) (2200 Ci/mmol; PerkinElmer Life and Analytical Science) for 20 min. The cells were harvested onto filter paper GF/B filters presoaked in 0.5% polyethyleneimine and washed with PBS using a 24-channel cell harvester (Brandel). Radioactivity of bound 125 I-epi was determined by gamma counting (PerkinElmer Life and Analytical Science). Nonspecific binding was estimated by 125 I-epi binding done on parallel samples preincubated with 1 mM nicotine.
To obtain antibody-precipitated counts, the cells were solubilized in lysis buffer (see above) following 17 h of nicotine exposure. Insoluble material was pelleted by centrifugation, which removed ϳ25% of the available 125 I-epi binding sites. The lysates were subjected to immunoprecipitation with various subunit-specific Abs. The antigen-antibody complexes were pulled down using protein G-Sepharose beads (GE Healthcare). Following immunoprecipitation the beads were bound with 2.5 nM 125 I-epi for 1 h. Binding was done in the presence of 1 mM nicotine to determine the nonspecific counts. The radioactivity associated with the beads was determined using gamma counting. The Abs used were tested on cell lines expressing ␣4␤4, ␣3␤2, or ␣6␤2 to determine their specificity. The ␤2-specific Abs did not precipitated measurable 125 I-epi counts from ␣4␤4-expressing cells, and ␣4-specific Abs did not precipitate 125 I-epi counts from ␣3␤2-or ␣6␤2-expressing cells. Primary cultures of cortical neurons were treated with 1 M nicotine for 17 h. The cells were gently scraped off the plates and resuspended in 1 nM 125 I-epi for 20 min. The neurons were vacuum harvested to GF/B filter (Brandel), and the specific radioactivity associated with the filters was measured as described above. In the case of antibody precipitation, the neurons were exposed to nicotine as described above and lysed with lysis buffer containing 1% Triton X-100 and protease inhibitors. The neuronal lysates were incubated with subunit-specific Abs overnight followed by protein G-Sepharose precipitation. The immunoprecipitated receptors were bound with 0.5 nM 125 I-epi for 1 h. The beads were washed three times with lysis buffer, and the radioactivity remaining on the beads was determined using gamma counting.
RT-PCR analysis. Total RNA was isolated from primary cortical cultures using a Purelink RNA mini kit (Invitrogen). Total RNA was reverse transcribed using random hexamer primers and multiscribe reverse transcriptase according to manufacturer's protocol (RT kit; Applied Biosystem). Reactions lacking RNA or reverse transcriptase served as control for DNA contamination or genomic amplification, respectively. PCR primers were designed based on published protocols (Sheffield et al., 2000; Rogers et al., 2001 ) and the conditions used therein were followed. Primer pairs are listed for each nicotinic receptor subunit: nAChR␤2, sense 59-GGAGTGGGAA GATTACCGCCTCA, antisense 5Ј-AGTCGTCGTGGTTCTCGTTGCG; nAChR␤3,sense5Ј-GCTGAACACGAAGACGC,antisense5Ј-GCAAAGAC AGTCACC; nAChR␤4, sense 5Ј-AGAGTGCCTGCAAGATTGAG, antisense 5Ј-AGCTGACTGCAGACTTAGGA; nAChR␣2, sense 5Ј-GATCTG GATCCCAGACATTG, antisense 5Ј-CGCCGATGAGTGGGATGACC; nAChR␣3,sense5Ј-GGTGGATGACAAGACCAAAGC,antisense5Ј-AGGG CAGGTAGAAGACAAGCA; nAChR␣4, sense 5Ј-CACGGTCTTCGTGCT CAATGT, antisense 5Ј-CCTTGGTTGCAGATGTCACTC; nAChR␣5, sense5Ј-GCTGCGCTGCTCTTGATGGT,antisense5Ј-CGTATGTCCACG AGCCGAAT; nAChR␣6, sense 5Ј-GCTTCATCCGGCCAGTGG, antisense 5Ј-GCAAAGAGTCACTTTCTCG; nAChR␣7, sense 5Ј-CGCTGGTTCCCT TTTGATGTG, antisense 5Ј-CTATCAAGGGCACAGAATCAG; ␤-actin, sense5Ј-AAGATCCTGACCGAGCGTGG,antisense5Ј-CAGCAGTGTGTT GGCATAGAGG; ChAT, sense 5Ј-GCCACTTGCATAGGTGAGGGC, antisense 5Ј-GCCACTAGTCAGTTGGGC.
Immunocytochemistry. Cortical neurons were plated on coverslips precoated with poly-D-lysine. On 11 d in vitro (DIV), neurons were fixed with 4% paraformaldehyde for 10 min, quenched with 100 mM glycine for 10 min, and permeabilized with 0.1% Triton X-100 for 10 min. Blocking of nonspecific sites was performed with 5% normal donkey serum and 0.1% fish gelatin in PBS for 1 h before incubating with primary Abs in blocking solution for 1 h. Abs and dilutions used were as follows: MAP-2 (1:1000), GFAP (1:1000), GAD65 (1:1000), mAb299 (1:500), and mAb270 (1:500). Cells were then incubated in appropriate secondary Abs (1:1000) for 1 h at room temperature. In some cases, nuclei were labeled with Hoechst dye for 5 min. Cells were mounted in ProLong gold and allowed to cure for 24 h before imaging on the Olympus DSU spinning disk (Integrated Microscopy Facility, University of Chicago, Chicago, IL). Samples prepared without primary antibody served as control for background fluorescence.
Biotinylation assays. Cell-surface proteins were biotinylated using 0.5 mg/ml EZ-link sulfo-NHS-SS-Biotin (ThermoFisher Scientific) for 20 min on ice. The cells were washed three times with PBS followed by DMEM and maintained in DMEM for the remaining time of chase. At the end of the chase period, cells were washed two times with PBS and solubilized in lysis buffer containing 1% Triton X-100 and protease inhibitors. Lysates were incubated overnight with streptavidin agarose (EMD Chemicals). The biotinylated receptors were detected by either 125 I-epi binding to beads or by immunoblots using subunit-specific Abs. In the instance of 125 I-epi binding, the streptavidin agarose beads were incubated with 2.5 nM 125 I-epi for 1 h. To determine nonspecific binding, 125 I-epi binding was done in the presence of 1 mM nicotine. The beads were spun down by centrifugation at high speed for 30 s and washed three times with lysis buffer. The radioactivity remaining on the beads was determined using gamma counting. (PerkinElmer). When subunits where detected by immunoblots, the biotinylated proteins were eluted from streptavidin agarose beads using 2ϫ concentration of SDS sample buffer, denatured by boiling, and subjected to SDS-PAGE. The proteins were electrotransferred to PVDF membrane (Bio-Rad) and blots were probed with Abs specific for ␣4 (6963) and ␤2HA (anti-HA).
Proteasome inhibitors. Cells stably expressing ␣4␤2HA were treated with the proteasomal inhibitors 1 M MG132, 1 M lactacystin, or 10 M nicotine for 4 h. At the end of the incubation, cells were scraped and resuspended in PBS, and subjected to 125 I-epi binding. A parallel set of samples treated with nicotine or MG132 were lysed in lysis buffer (150 mM NaCl, 5 mM EDTA, 50 mM Tris, pH 7.4, 0.02% NaN3, plus 1% Triton X-100) containing protease inhibitors (2 mM PMSF, 2 mM N-ethylmaleimide, and chymostatin, pepstatin, leupeptin, and tosyllysine chloromethyl ketone at 10 g/ml), and wholecell lysates were subjected to SDS-PAGE analysis, proteins were transferred to PVDF membranes, and Western blots were probed with 6963 (␣4), anti-HA (␤2HA), or anti-actin (loading control).
Primary cultures of cortical neurons (10 DIV) were treated with proteasomal inhibitors 1 M MG132, 1 M lactacystin, or 1 M nicotine for 17 h, and 125 I-epi binding was done on intact neurons. Parallel samples treated with nicotine and MG132 were processed as described above and subjected to SDS-PAGE. Proteins were transferred to PVDF membranes followed by Western blotting using Abs 6963 (␣4) and anti-actin. Alexa Fluor anti-rabbit 647 was used to detect the ␣4 subunits and actin. The blots were scanned using the Bio-Rad pharos-FX laser scanner. The band intensities were quantified using ImageJ software (NIH).
Statistical analysis. Results are expressed as mean Ϯ SEM of n samples. Statistical significance was assessed by a two-tailed Student's t test.
Results

nAChR high-affinity binding sites in live cortical neurons
Using cultured rat cortical neurons, we measured high-affinity 125 I-epi binding to endogenous nAChRs. Neurons, 10 -12 DIV, were exposed to 1 M nicotine for 17 h to examine the increase or "upregulation" in 125 I-epi binding to live neurons. Nicotine treatment caused a threefold increase in 125 I-epi binding on average (27.6 Ϯ 2.4 SEM fmol/mg total protein for untreated, 70.4 Ϯ 4.5 SEM fmol/mg total protein for nicotine treated) and varied over a range of twofold to fourfold. By varying the concentration of nicotine in the medium, we assayed the nicotine dose dependence of the upregulation of the 125 I-epi binding for cortical neurons (Fig. 1 A) . An EC 50 value of 92 nM was obtained by fitting the Hill equation to the data. Using a number of different techniques, we examined the subunit composition of native nAChRs in cortical neurons. Reverse transcription PCR was used to establish which mRNA transcripts were expressed in our cultures (Fig. 1 B) . We detected ␣3, ␣4, ␣7, ␤2, and ␤4 subunit transcripts, but not ␣2, ␣5, ␣6, and ␤3 subunit transcripts with oligonucleotide sequences already established to detect nAChR subunit transcripts (Sheffield et al., 2000; Rogers et al., 2001) . ␣7 subunits primarily assemble into homomeric nAChRs that bind 125 I-␣-bungarotoxin, but not radiolabeled agonists such as 125 Iepi (Clarke et al., 1985; Härfstrand et al., 1988; Pauly et al., 1989) . We, therefore, assayed ␣3, ␣4, ␤2, and ␤4 subunits at the protein level using subunit-specific Abs for each subunit. Abs specific for each of these subunits were used to precipitate nAChRs from the lysate and 125 I-epi binding performed on the immunoprecipitated nAChRs. The percentage of available epibatidine binding sites precipitated by each of the subunit-specific Abs was determined. ␣4-and ␤2-specific Abs precipitated a significant percentage of the available 125 I-epi binding sites in the cortical neurons, while relatively few of the 125 I-epi binding sites were precipitated by ␣3-and ␤4-specific Abs (Fig. 1C) . Similarly using immunoblots, ␣4 subunits were immunoprecipitated by ␣4-and ␤2-specific Abs (Fig. 1 D) . The expression of native "␣4␤2" receptors was further assayed using immunofluorescence microscopy ( Fig. 1 E, F ) . ␣4-and ␤2-specific Abs only stained neurons that were labeled with MAP-2 Abs and not astrocytes labeled with GFAP Abs (Fig. 1 E) . ␣4-specific Abs stained inhibitory neurons labeled with GAD65 Abs and other neurons presumed to be excitatory (Fig. 1 F) . Altogether, our results indicate that the native high-affinity 125 I-epi binding sites that are upregulated by nicotine in the cortical neurons contain primarily ␣4 and ␤2 subunits and are the "␣4␤2" subtype.
Real-time kinetics of nicotine-induced upregulation onset and reversal
We next measured how exposure of cortical cultures to nicotine altered high-affinity 125 I-epi binding to native nAChRs in real time. Cortical neuronal cultures were treated with 1 M nicotine for varying times, and 125 I-epi binding was determined for nicotine-treated and untreated cultures at the different time points. The ratio of 125 I-epi binding of nicotine-treated to untreated cultures or the fold-increase in 125 I-epi binding was used as a quantitative measure of nicotine-induced upregulation. The time course of upregulation after application of nicotine is displayed in Figure 2 A. The onset of upregulation occurred at two different rates. First, there was a fast component that saturated 4 h after exposure and later a slower component that increased subsequently with continued nicotine exposure. Consistent with the presence of two separate processes, the data were only well fit as the sum of two exponential functions with a fast component ( ϭ 1.1 h) and a slower component ( ϭ 12.5 h).
The two components of nicotine-induced upregulation were more evident when nicotine was removed from the medium after both components of upregulation were saturated with nicotine treatments (Fig. 2 B) . Nicotine withdrawal initially caused a rapid decrease in the 125 I-epi binding fold-increase. This fast component was followed by a much slower decay that continued days after nicotine withdrawal ( Fig. 2 B, insert) . The decay rate following nicotine withdrawal was again well fit as the sum of two separate processes. The fast component decayed with a value of 0.45 h, and the slow component decayed with a value of 12.3 d. The slow component of the decay of nicotine-induced upregulation after nicotine removal was not observed if cultures were exposed to nicotine for Յ4 h (Fig. 2C ). The kinetics of the fast component of upregulation during onset was similar to the fast decay during withdrawal, and the slow onset of upregulation was similar to the slow component of decay. These results suggest that the fast components of upregulation represent the same process either turning on during onset or turning off during reversal. They also suggest that the slow components are a second slow process turning on and off. In summary, we find that the nicotine-induced upregulation kinetics contains two components indicating that at least two different processes are causing upregulation. We also observed a similar biphasic decay of nicotine-induced upregulation for ␣4␤2 and ␣6␤2 receptors heterologously expressed in HEK 293 cells (Fig. 2 D 
, E).
The kinetics of nAChR degradation during nicotine withdrawal
We began to test what mechanisms underlie the two different rates at which decay of upregulation occurred. A previous study from our laboratory found that changes in high-affinity binding with nicotine-induced upregulation did not correlate with changes in the number of ␣4␤2 nAChRs stably expressed in HEK 293 cells (Vallejo et al., 2005) . However, if 125 I-epi binding is a measure of receptor numbers, then the rates of decay of upregulation with nicotine withdrawal should correlate with the rate of degradation of the mature receptor complexes that bind 125 I-epi. To determine the rates of nAChR subunit assembly and degradation, we used a pulse-chase approach to label the subunits with radiolabeled amino acids (Merlie and Lindstrom, 1983; Green and Claudio, 1993; Sallette et al., 2005) . Unfortunately, these experiments could not be performed using cultured cortical neurons because of the limited number of neuronal cells and relatively low levels of nAChR expression. As an alternative, we performed pulse-chase measurements on rat ␣4 and ␤2 subunits stably expressed in HEK cells that were previously used to study nicotine-induced upregulation (Vallejo et al., 2005) , which also displayed fast and slow phases of the decay of upregulation following nicotine withdrawal (Fig. 2 D) . The subunits in the ␣4␤2 stable cell line were metabolically labeled with 35 S-methionine/ cysteine for 15 min. Subsequently, cells were solubilized at various chase times following nicotine withdrawal. Subunits were immunoprecipitated with several different ␣4-and ␤2-specific Abs 7-9 h following nicotine removal and intensities of 35 Slabeled bands measured. Examples of the results are displayed in Figure 3A . Our results were similar to previous pulse-chase analysis performed on human ␣4 and ␤2 subunits transiently ex- n ϩ 1, where Max ϩ 1, the maximum fold-increase was 2.6; n, Hill coefficient was 1.8; and the EC 50 value was 92 Ϯ 30 nM. B, RT-PCR analysis of nAChR subunit transcript expression. RNA isolated from primary cortical neurons was subjected to RT-PCR analysis and run on an agarose gel, which showed the expression of the various nAChR subunit mRNAs in addition to actin and choline acetyl transferase (CHAT) as controls. A faint band was observed in the ␣6 lane, which did not correspond to the expected size of the transcript. C, Precipitation of 125 I-epi binding sites from cortical neurons. Primary cultures of cortical neurons were treated with or without 1 M nicotine for 17 h and bound with 1 nM 125 I-epi for 20 min to obtain the total epibatidine sites. Parallel samples were solubilized and precipitated with subunit-specific antibodies 6963 (␣4), 4880 (␣3), mAb270 (␤2), and 4886 (␤4). Data are represented as the average percentage of total epibatidine binding precipitated Ϯ SEM (n ϭ 3 for 4880 and 4886; n ϭ 5 for 6963 and mAb270; see Fig. 6C ,D for more details). D, Total ␣4 subunits immunoprecipitated (IP) by ␣4-specific antibody mAb299 or assembled ␣4 subunits coimmunoprecipitated with ␤2-specific antibody mAb270 were detected on a Western blot (WB) using polyclonal anti-␣4 antibody, 6963. E, Cortical neurons were plated on glass coverslips and fixed, permeabilized, and costained with Abs for MAP-2 and ␣4 (mAb299) to the left or glial marker GFAP and anti-␤2 (mAb270) to the right followed by fluorescent secondary Abs. F, Cortical neurons were stained with Ab marker for inhibitory neurons (GAD65 Ab) and costained with mAb299 (anti-␣4). Secondary antibody staining was done with Alexa Fluor anti-mouse 568 and anti-rat 488.
pressed in HEK cells (Sallette et al., 2005) . Subunit assembly as assayed by increases in subunit coprecipitation peaked over the first 60 -90 min. The peak in subunit assembly was followed by a period over the next 5-8 h where subunit degradation predominated, as assayed by decreases in subunit band intensities. Differences in the assembly of the subunits were observed depending on which Ab was used, and these differences are further described in more detail later (see Fig. 6 ). However, the rate of subunit degradation was independent of the Ab used for immunoprecipitation.
The averaged results of the 35 S-labeled band intensities precipitated by the different subunit-specific Abs are displayed in Figure 3 , B and C, and were used to approximate rates of degradation of the ␣4 and ␤2 subunits after nicotine withdrawal. The rates of degradation of the newly synthesized subunits were relatively fast ( ϭ 3-6 h), but significantly slower than the fast phase of the decay of upregulation after nicotine withdrawal ( ϭ 0.76 h; see Table 1 ). The degradation rate was not significantly different whether the cells were treated or untreated with nicotine. As discussed by Sallette et al. (2005) , the kinetics of ␣4 and ␤2 subunit assembly and degradation in the ER are complex and are the combination of several processes including the degradation of unassembled subunits, the assembly of immature subunit complexes, and the maturation of the subunit complexes. Surprisingly, the degradation rate for the newly assembled subunits (subunits that coprecipitated) was not significantly different from the degradation rate for the total cellular pool of subunits or the rate for unassembled subunits determined by stable expression of ␣4 subunits alone (data not shown). Using the pulsechase analysis, we primarily precipitated a rapidly degrading pool of labeled subunits. The pool of mature nAChRs that is trafficked to the cell surface and degraded at a slower rate is a small proportion of the total subunit pool that is labeled during synthesis. Following loss of the rapidly degrading pool of labeled subunits, the levels of remaining subunits indicate that Ͻ20 -30% of newly synthesized subunits are further assembled into the mature pool of nAChRs ( Fig.  3 B, C) .
Next, we used cell-surface biotinylation to assay the degradation rate of mature cellsurface nAChRs after nicotine withdrawal (Fig. 3D) . Cell-impermeable biotinylation reagents were used to biotinylate nAChRs on the surface of intact cells. Surface nAChRs on intact cells were briefly biotinylated with membrane-impermeable reagents at the end of the nicotine treatment (10 M nicotine, 17 h). After biotinylation and nicotine treatment, the cells were chased for the indicated times in the absence of nicotine, and subunit band intensities were determined from immunoblots of the surface-biotinylated subunits (Fig. 3D) . The decay of the surface receptor ␣4 and ␤2 subunit bands as a function of time after biotinylation and nicotine withdrawal in Figure 3D is a measure of the rate of degradation of the surface nAChRs. We observed no significant differences in the rates of degradation for the ␣4 and ␤2 subunits, whether the surface nAChRs had been nicotine pretreated or untreated. The decay of the band intensities after nicotine with- . The line represents a least-squares fit to the sum of two exponentials or fold-increase ϭ m1 * (1 Ϫ exp(Ϫt/1)) ϩ m2 * (1 Ϫ exp(Ϫt/2)) ϩ 1 where m1 and m2 are the maximal values for the two exponentials (m1 ϭ 0.89, m2 ϭ 0.74) and 1 and 2 are the respective time constants (1 ϭ 1.1 h, 2 ϭ 12.5 h). B, Decay of high-affinity nicotine-binding sites following nicotine withdrawal. Primary cultures of cortical neurons were treated with or without 1 M nicotine for 17 h, and the cultures were washed three times with neurobasal medium and maintained in preconditioned media lacking nicotine for the indicated times. Highaffinity binding sites remaining were measured using 1 nM 125 I-epi bound for 20 min. Displayed in the main figure are the data for thefirst24hafternicotineremovaltoshowthedetailsofthefastdecay.Thefulltimecourseofthedecayover11disdisplayedintheinsert. DataaremeanϮSEMoffourindependentexperimentsperformedintriplicate.Thelinesthroughthepointsrepresentstheleast-squarefit tothedataoftheequation:foldincreaseϭm1(exp(Ϫt/1))ϩm2(exp(Ϫt/2))ϩ1,wherem1andm2aretheinitialvaluesforthetwo exponentials (m1 ϭ 2.4, m2 ϭ 1.12) and 1 and 2 are the respective time constants (1 ϭ 0.45 h, 2 ϭ 295 h). C, Nicotine-induced upregulationaftershortexposurestonicotine.Primaryculturesofcorticalneuronsweretreatedwithorwithout1Mnicotinefor1,2,or4h andcultureswerewashedandmaintainedinnicotine-freemediaasmentionedaboveforindicatedtimesand 125 I-epibindingperformed. Each point is the mean Ϯ SEM (n ϭ 3). The data were fit to the equation m(expϪt/) ϩ 1, where m is the initial value and is the time constant. The values are 0.5, 0.9, and 1.1 h, respectively, for 1, 2, and 4 h time points. For comparison, the data from the 24 h treatment from B are also displayed. D, HEK 293 cells stably expressing ␣4␤2HA receptors were treated with or without 10 M nicotine for 17 h and washedandmaintainedinmediumwithoutnicotinefortheindicatedtimes.High-affinitybindingsitesremainingweremeasuredusing5 nM 125 I-epi bound for 20 min. Data are mean Ϯ SEM (n ϭ 5). The lines through the points are the least-squares fit of fold-increase ϭ m1(exp(Ϫt/1)) ϩ m2 (exp(Ϫt/2)) ϩ1, where m1 and m2 are the initial values for the 2 exponentials (m1 ϭ 1.3, m2 ϭ 2.5), and 1 and 2 are the respective time constants (1 ϭ 0.76 h, 2 ϭ 44 h). E, HEK293 cells stably expressing ␣6Flag␤2HA were treated with 30 M nicotine for 17 h to achieve maximum upregulation and then grown in the absence of nicotine for the indicated times. High-affinity binding sites remaining were measured using 2.5 nM 125 I-epi bound for 20 min. Data are mean Ϯ SEM (n ϭ 6). The lines were the fits to the equation in D (m1 ϭ 1.0, m2 ϭ 2.46; 1 ϭ 0.94 h, 2 ϭϳ500 h). Because the HEK cells stably expressing ␣6␤2 receptors did not survive much beyond 48 h after the nicotine removal, the estimate of 2 is an approximate. Nic, Nicotine.
drawal was well fit as a single exponential process with a mean of 35 h. Thus, mature ␣4␤2 nAChRs are degraded at rates much slower than the newly assembled receptor subunits assayed in Figure 3 , B and C, consistent with the degradation rates that had been previously measured for ␣4␤2 nAChRs (Darsow et al., 2005) and other nAChRs (Christianson and Green, 2004) .
We also examined the kinetics of 125 I-epi binding to the plasma membrane pool of ␣4␤2 receptors after nicotine withdrawal. To do this, 125 I-epi binding was performed on the solubilized, surface-biotinylated ␣4␤2 nAChRs as a function of time after nicotine withdrawal (Fig. 3E) . The reversal of 125 I-epi binding to the surface-biotinylated nAChRs displayed both the fast and slow components similar to that observed when the 125 I-epi binding was done on the whole-cell population of nAChRs (Fig.  2 B, D) . Because the fast component was not observed when the degradation of surface nAChRs was assayed (Fig. 3D) , the 125 Iepi binding that rapidly reverses after nicotine withdrawal in Figure 3E cannot be caused by surface nAChR degradation or any 35 S-labeled subunits precipitated with different ␣4-and ␤2-specific Abs. Cell line stably expressing ␣4␤2 receptors was treated with 10 M nicotine for 17 h to achieve maximum upregulation. The cells were metabolically labeled with 35 S-met/cys for 15 min and chased in the absence of nicotine (withdrawal). Subunits were immunoprecipitated (IP) with ␣4-specific Abs, polyclonal 6963 or mAb299 or ␤2-specific Abs, mAb270 or polyclonal anti-␤2 (SC), and subjected to SDS-PAGE. B, C, Degradation of newly synthesized subunits after nicotine withdrawal. Band intensities in A are plotted as a function of the chase time and are the mean Ϯ SEM (n ϭ 3) for ␣4 or ␤2 subunits precipitated by both Abs. Only the values beginning at the 1 h time point are displayed, the time when the band intensities began to decay. Displayed in B are the values for the newly synthesized ␣4 or ␤2 subunits immunoprecipitated by the Abs ("Total" subunits). The data were fit to single exponential equations: percentage of subunits remaining ϭ 100%(exp(Ϫt/)) where is the characteristic decay rate. The values were 3.2 h for ␣4 subunits and 5.9 h for ␤2 subunits for no nicotine treatment and 3.9 h for ␣4 subunits and 5.2 h for ␤2 subunits for nicotine pretreatment. Displayed in C are the values for ␣4 or ␤2 subunits that coimmunoprecipitated with the precipitated subunits ("Assembled" subunits). The values were 5.8 h for ␣4 subunits and 5.3 h for ␤2 subunits for no nicotine treatment, and 4.4 h for ␣4 subunits and 5.6 h for ␤2 subunits for nicotine pretreatment. D, Degradation of surface ␣4␤2 nAChRs after nicotine withdrawal. Cells expressing ␣4␤2 nAChRs were treated with or without 10 M nicotine for 17 h. Surface receptors were biotinylated and maintained at 37°C in the absence of nicotine for indicated times. Cells were lysed and biotinylated surface nAChRs precipitated with streptavidin agarose and analyzed by SDS-PAGE and immunoblots. Subunits on immunoblots were detected using ␣4-specific (polyclonal 6963) or ␤2-specific (anti-HA) Abs. The intensity of subunits remaining at each time point was plotted as a function of time Ϯ SEM (n ϭ 3). The lines through the data points represent fits of the equation to the data: percentage of subunits remaining ϭ m(expϪt/), where m is the initial value and is the decay rate. The values in untreated cells were 32.5 h for ␣4 and 49.5 h for ␤2 and that of nicotine pretreated cells were 32.2 h for ␣4 and 38.2 h for ␤2. E, Decay of 125 I-epi binding to cell surface receptors following nicotine withdrawal. Cells expressing ␣4␤2 nAChRs were upregulated with 10 M nicotine for 17 h or left untreated and subsequently surface biotinylated and lysed at the indicated times. Surface nAChRs were precipitated with streptavidin agarose after 125 I-epi binding. The data are plotted as the ratio of precipitated 125 I-epi counts for nicotine pretreated samples to untreated samples and displayed as the percentage of the initial value. The points and error bars are the mean Ϯ SEM (n ϭ 3). The lines through the data points are least-squares fits of the equation to the data: percentage of initial value ϭ m1(exp(Ϫt/1)) ϩ m2 (exp(Ϫt/2)) ϩ1, where m1 and m2 are the initial values (m1 ϭ 81%, m2 ϭ 19%) and 1 and 2 are the respective time constants (1 ϭ 1.2 h, 2 ϭ 45 h).
change in surface nAChR numbers. These findings regarding the rapid phase of nicotine-induced upregulation are in agreement with our previous conclusions about mechanisms underlying nicotine-induced upregulation for ␣4␤2 nAChRs stably expressed in HEK 293 cells (Vallejo et al., 2005) . However, in the previous study, we did not measure the effects of nicotine withdrawal and, thus, did not observe the second component of upregulation. We find that the slow decay rate of the second upregulation component ( ϭ 45 h; see Table 1) , unlike the first, does correlate with the rate of degradation of the surface nAChRs (mean ϭ 35 h). These results demonstrate that a second set of mechanisms, which changes the number of nAChRs, cause the slow component of nicotine-induced upregulation.
Kinetics of degradation of nAChRs during nicotine exposure
During nicotine withdrawal, the degradation rate of newly synthesized subunits did not differ between cells that were nicotine pretreated or left untreated (Fig. 3A-C) . However, when nicotine treatment was maintained (10 M nicotine for 17 h), we observed significant differences in the degradation rate for newly synthesized ␤2 subunits in the total and assembled pool, but less so for ␣4 subunits (Fig. 4 A-C) . The degradation rate of mature nAChRs on the cell surface was not altered by nicotine treatment as shown previously (Darsow et al., 2005; Vallejo et al., 2005) . Thus, maintained exposure to nicotine slows the degradation rate of newly synthesized subunits, largely ␤2 subunits (Fig. 4 B) , leading to increased assembly of receptors.
Proteasome-mediated degradation of nAChR subunits causes the slow component of upregulation
We next examined the mechanisms causing the slow phase of nicotine-induced upregulation. Degradation of the newly synthesized subunits is likely occurring in the ER, similar to other nAChRs (Christianson and Grailhe et al., 2004) . We had found that ER-associated degradation (ERAD) of the nAChR subunit was mediated by proteasomes, as evidenced by increases in subunit levels and their assembly in the ER after blocking proteasome activity (Christianson and Green, 2004) . To similarly test whether a loss of proteasome activity results in increases in ␣4 and ␤2 subunit levels in the ER, we compared the effects of the proteasome inhibitor, MG132, and nicotine treatment on the levels of ␣4 and ␤2 in the ␣4␤2-expressing HEK cell line. Treatment of the cells with MG132 caused a twofold increase in the steady-state levels of both ␣4 and ␤2 subunits (Fig. 5A , left, middle left, middle right). Nicotine treatment resulted in a twofold increase in ␤2 subunit steady-state levels (Fig. 5A , left, middle right) but had a much smaller effect on ␣4 subunit levels (1.3-fold; Fig. 5A , left, middle left), consistent with the greater effect nicotine had on the rate of ␤2 subunit degradation compared with ␣4 subunit degradation (Fig. 4 B, C) . In contrast to a previous study, which suggested that nicotine directly inhibits proteasomal activity (Rezvani et al., 2007) , we observe a differential effect of nicotine treatment on ␣4 and ␤2 subunit levels compared with the proteasomal block suggesting that nicotine is not directly inhibiting proteasomal activity in the conditions measured in this study. We obtained additional evidence that nicotine is not directly inhib- 35 S-labeled subunits precipitated with different ␣4-and ␤2-specific Abs during sustained nicotine exposure. Cell line stably expressing ␣4␤2 receptors was treated with 10 M nicotine for 17 h to achieve maximum upregulation. The cells were metabolically labeled with 35 S-met/cys for 15 min and chased in the presence of nicotine (upregulation). Subunits were immunoprecipitated (IP) with ␣4-specific antibodies, polyclonal 6963 or mAb299 or ␤2-specific Abs, or mAb270 or polyclonal anti-␤2 (SC), and subjected to SDS-PAGE. B, C, Degradation of newly synthesized subunits during nicotine exposure. ␣4␤2-expressing HEK cells were treated as in Figure 3A -C, but instead newly synthesized subunits were chased in culture for the indicated time intervals in the presence or absence of nicotine. Cells were lysed and immunoprecipitated with the Abs described. Band intensities are plotted as a function of the chase time and are the mean Ϯ SEM (n ϭ 3) for ␣4 or ␤2 subunits precipitated by both Abs. Only the values beginning at the 1 h time point are displayed, the time when the band intensities began to decay. Displayed in B are the values for the newly synthesized ␣4 or ␤2 subunits immunoprecipitated by the Abs ("Total" subunits). The data were fit to single exponential equations: percentage of subunits remaining ϭ 100%(exp(Ϫt/)) where is the characteristic decay rate. The values for untreated cells were 4.0 h for ␣4 and 5.8 h for ␤2 and 4.0 h for ␣4 and 11.2 h for ␤2 for nicotine-treated cells. Displayed in C are the values for the newly synthesized ␣4 or ␤2 subunits that coimmunoprecipitated with the precipitated subunits ("Assembled" subunits). The values for untreated cells were 5.8 h for ␣4 and 5.5 h for ␤2 and 7.6 h for ␣4 and 11.7 h for ␤2 for nicotine-treated cells. iting proteasomes when ␣4 and ␤2 subunits were stably expressed individually in HEK cells (Fig. 5B) . Proteasomal inhibition still increased ␣4 and ␤2 subunit levels twofold, but nicotine treatment had no effect on ␣4 and ␤2 subunit levels when expressed individually (Fig. 5B, left, middle, right) . These results suggested that the nicotine-induced effects on ␣4 and ␤2 subunit levels and degradation rates require the presence of both subunits and subunit assembly in cells.
Inhibition of proteasomes had similar effects on nicotineinduced upregulation of ␣4␤2 nAChRs in cortical neurons. Only ␣4 subunit levels could be measured using immunoblots for cortical neurons. Similar to the ␣4␤2 HEK cell line proteasomal inhibition and nicotine-induced upregulation increased ␣4 subunit levels, a 1.7-fold increase with MG132 treatment and a 1.2-fold increase with nicotine treatment (Fig. 5C, middle) . A significantly smaller fold-increase in 125 I-epi binding was observed with protease inhibitors (MG132 and lactacystin) than for nicotine-induced upregulation for both cortical neurons (Fig.  5C , right) and ␣4␤2-expressing cells (Fig. 5A, right) even though proteasomal inhibition increased subunit levels to a greater extent. Thus, it appears that nicotine binding to pre-existing nAChRs induces a decrease in proteasome-mediated degradation of nAChR subunits, primarily ␤2 subunits, during ERAD. Slowing of ␤2 subunit ERAD increases the number of subunits that assemble into nAChRs in the ER. Increased nAChR assembly, in turn, increases nAChR numbers and 125 I-epi binding at intracellular and surface sites, similar to what was found previously with muscle nAChR subunits when ERAD was blocked (Christianson and Green, 2004) .
Nicotine-induced nAChR conformational changes occur during the fast phase of upregulation
We also investigated the mechanisms responsible for the fast component of nicotine-induced upregulation that occur following nicotine withdrawal. In Figure 3 , we found that the fast decay of nicotine-induced upregulation during nicotine withdrawal does not correspond to a change in the number of nAChRs. If not a change in the number of nAChRs, what causes the decay in 125 I-epi binding? We had previously proposed that nicotine induces a conformational change during upregulation causing nAChRs to transition from a low-affinity resting state to a highaffinity upregulated state (Vallejo et al., 2005) . Evidence of this conformational change during upregulation was a change in the ␣4␤2 nAChR functional state with upregulation (Buisson and Bertrand, 2001; Vallejo et al., 2005) . Another assay of nAChR conformational changes is the interaction between nAChRs (n ϭ 4) . B, Effects of nicotine and proteasome inhibitors on ␣4 and ␤2 subunits expressed alone. Left, HEK cells stably expressing either ␣4 or ␤2 subunit alone were treated with or without 10 M nicotine or 1 M MG132 for 4 h. Whole-cell lysates were subjected to SDS-PAGE and immunoblotted with anti ␣4 (6963) and anti-HA (␤2) Abs. Middle, Quantification of band intensity of ␣4 subunit following nicotine or MG132 treatment normalized to control levels in left panel Ϯ SEM (n ϭ 3). Right, Quantification of band intensity of ␤2 subunits following nicotine or MG132 treatment normalized to control levels in, first panel Ϯ SEM (n ϭ 3). C, Effects of nicotine and proteasome inhibitors on endogenous nicotinic receptors expressed in cortical neurons. Left, Primary cultures of cortical neurons (10 DIV) were treated with 1 M nicotine, 1 M MG132, or vehicle for 17 h. Lysates (from two 6 cm plates) were loaded on SDS-PAGE, and proteins were transferred to PVDF and immunoblotted with 6963 (␣4) or anti-actin (loading control). Middle, Quantification of band intensity of ␣4 subunit normalized to control levels in the left panel Ϯ SEM (n ϭ 3). Right, 125 I-epi binding was performed on primary cultures of cortical neurons treated with 1 M nicotine, 1 M MG132, or 1 M lactacystin as described above Ϯ SEM (n ϭ 3).
and monoclonal Abs (mAbs) with conformational-dependent epitopes. Conformational-dependent mAbs have been used to assay for muscle-type nAChR subunit conformational changes that occur during nAChR assembly and maturation in the ER (Merlie and Lindstrom, 1983; Green and Claudio, 1993) . We tested a number of ␣4-and ␤2-specific Abs to examine whether their associations with mature 125 I-epi-bound ␣4␤2 nAChRs were altered by nicotine treatment. To assay for changes in Ab-nAChR associations caused by nicotine treatment, we measured the percentage of 125 I-epi binding that was precipitated by each Ab for nicotine-treated and untreated cells. This percentage was obtained from the ratio of Ab-precipitated 125 I-epi binding counts to total cellular 125 I-epi binding for intact cells that were either nicotine treated or untreated. Using the stable ␣4␤2-expressing cell line (Fig. 6 A) , two of the Abs tested showed no change in the precipitation of 125 I-epi-bound nAChRs with nicotine treatment. The polyclonal Abs tested precipitated a higher percentage of the total 125 I-epi binding counts. Three of the Abs tested showed large increases in the precipitation of 125 I-epibound nAChRs with nicotine treatment, but precipitated a smaller percentage of the total 125 I-epi binding counts even for the nicotinetreated cells. Two of the Abs that showed nicotine-induced changes in the precipitation of 125 I-epi-bound nAChRs, ␤2-specific mAb 270, and ␣4-specific mAb 299 were mAbs whose interactions with nAChRs were previously shown to be dependent on subunit conformation (Harkness and Millar, 2002) . These findings indicate that mAb 270 and 299 epitopes become more accessible for binding after nicotine treatment while the availability of the ␣4-and ␤2-specific polyclonal Ab epitopes does not change after nicotine treatment. Surprisingly, a third Ab, specific for the HA epitope that was fused to the ␤2 subunit C terminus, also showed similar increases in the precipitation of 125 I-epi-bound nAChRs with nicotine treatment, suggesting that the HA epitope was changing with nicotine treatment becoming more accessible for Ab binding similar to mAbs 270 and 299.
We performed the same experiments with cortical neurons (Fig. 6C,D) and observed similar results. The HA-specific mAb could not be used because the native ␤2 subunits lack the HA epitope. The ␣4-and ␤2-specific polyclonal Abs precipitated the same percentage of 125 I-epibound nAChRs whether the neurons had been nicotine treated or untreated (Fig.  6C,D) . The ␤2-specific polyclonal Ab precipitated a smaller percentage of the 125 Iepi bound nAChRs compared with the ␣4␤2 cell line. The smaller percentage resulted from a new lot of ␤2-specific Ab that was less efficient for precipitation than the previous lot. The new lot also precipitated a similar smaller percentage of 125 I-epi-bound nAChRs when repeated with the ␣4␤2 cell line (data not shown). The ␣4-specific polyclonal Ab precipitated the same percentage of the 125 I-epi-bound nAChRs where the same lot of Ab was used. As with the ␣4␤2 cell line, we observed a significant fold-increase in the percentage of precipitated 125 I-epi binding for mAbs 270 and 299 with nicotine treatment. The fold-increase for both mAbs was twofold, which is smaller than that observed in the ␣4␤2 cell line, consistent with the smaller fold-increase of upregulation (Fig. 6 E) . The percentage of the 125 I-epi-bound nAChRs precipitated by mAbs 270 and 299 was higher than the ␣4␤2 cell line. The higher percentage precipitated by the conformation-dependent mAbs may be caused by a higher efficiency of mature nAChR formation in the cortical neurons relative to the stable HEK cell line.
In a recent study, 125 I-epi binding measurements were performed on brain tissue from nicotine-or saline-treated mice. Contrary to what we observed for the native nAChRs in cortical neurons, nicotine treatment did not result in increases in mAb 270 or 299 associations with native nAChRs (Marks et al., 2011) . The differences between their findings and ours could result from a 2 h delay after nicotine treatment before processing the mice 125 I-epi counts pulled down by each of the Abs in A. mAb270, anti-HA mAb, and mAb299 precipitated a significantly larger percentage of total epibatidine counts in ␣4␤2 samples exposed to nicotine (t test; *p Ͻ 0.05), whereas polyclonal antibodies 6963 (␣4) and anti-␤2 (SC) precipitated a similar percentage of total 125 I-epi counts from nicotine-treated and nontreated cells. C, Immunoprecipitation of 125 I-epi binding sites from cortical neurons. Primary cultures of cortical neurons (10 DIV) were treated with or without 1 M nicotine for 17 h, and bound with 125 I-epi to obtain the total number of 125 I-epi sites. Parallel samples were lysed and precipitated with subunit-specific antibodies as in A. Data are represented as the average percentage of total binding precipitated Ϯ SEM (n ϭ 5). Similar to the cell line expressing ␣4␤2HA, mAb270 and mAb299 precipitated a significantly larger percentage of total epibatidine counts in cortical neurons exposed to nicotine (t test; *p Ͻ 0.05). D, Data in C are replotted as the ratio of the percentage of total 125 I-epi counts pulled down from nicotine-treated to untreated samples by each of the Abs used. E, HEK cells stably expressing ␣4␤2HA were treated with 10 M nicotine for 17 h and washed and maintained in nicotine-free media for3 h. 125 I-epi binding was performed on intact cells to obtain total 125 I-epi binding sites. Lysates were made from parallel samples, immunoprecipitated with indicated antibodies, bound with 125 I-epi, and data plotted as in Fig. 5B . F, Cortical neurons were treated with 1 M nicotine for 17 h and washed and maintained in nicotine-free media for 5 h.
125 I-epi binding was assayed on intact neurons to obtain the total 125 I-epi binding sites. Parallel samples were lysed and immunoprecipitated with indicated antibodies, bound with 125 I-epi, and data plotted as in Fig. 5D Ϯ SEM (n ϭ 3).
brains for epibatidine binding. In our cortical cultures, we found that 2 h after nicotine withdrawal, the fast component of upregulation had completely decayed and the fold-increase in 125 I-epi binding changed from 2.9 to 1.7 (Fig. 2 B) . Thus, the measurements made on brain tissue would have missed the fast component and would have only measured the slow component of nicotine-induced upregulation. Consistent with this, 125 I-epi binding in the cortical regions was increased only 1.5-fold on average by the nicotine treatment when measured by immunoprecipitation, and 1.7-fold by autoradiography. In a different study (Turner et al., 2011) , both the fast and slow components of nicotine-induced upregulation were observed when mice were killed without delay after a similar nicotine treatment and rapid membrane preparation. In this study, 3 H-epi binding to the cortical regions was increased to significantly higher levels (2.7-fold) by nicotine treatment similar to the levels we measured before nicotine was withdrawn from the cortical cultures. Furthermore, they found that the binding had decayed 24 h after treatment to a level (1.6-fold) consistent with our measurements of the slow component and was maintained at that level for 3 d. The results of these two studies would be consistent with our data on cortical cultures if a nicotine-induced ␣4␤2 conformational change, as assayed by the conformation dependence of mAb precipitation of 125 I-epi binding, is observed only during the rapid decay phase of the upregulation.
We, therefore, tested whether the nicotine-induced increases in mAb precipitations of nAChRs were only observed during the fast decay phase of the upregulation. For the cortical neurons, 5 h after nicotine withdrawal is a time when the fast component had completely disappeared and the slow component had not changed. Hence, 5 h after nicotine withdrawal we used the same sets of antibodies to assay changes in the percentage of 125 I-epi counts precipitated. At this time after nicotine withdrawal, the nicotine-dependent increases in the percentage of precipitated 125 I-epi-bound nAChRs had disappeared (Fig. 6 F) , consistent with nicotine-dependent changes in epitope availability occurring as part of the fast component and not the slow component of upregulation. We also tested in ␣4␤2 HEK cells whether conformational-dependent mAb precipitation of the 125 I-epibound nAChRs changed with the decay of the fast component of the upregulation (Fig. 6 E) . At a time after nicotine withdrawal when the fast component had completely disappeared and the slow component had hardly changed (3 h), the nicotinedependent increases in the percentage of precipitated 125 I-epibound nAChRs had disappeared (Fig. 6 E) . Thus, for the stably expressed ␣4␤2 nAChRs, as well as for the cortical neuron native ␣4␤2 nAChRs, the nicotine-dependent increases in mAb precipitation only occur during the fast phases of the nicotine-induced upregulation.
Discussion
While nicotine-induced upregulation of nAChRs is a well established phenomena linked to nicotine addiction, its role in nicotine addiction and the mechanisms responsible for upregulation are not established. Nonetheless, many different mechanisms have been proposed to explain how upregulation occurs. These include mechanisms that increase nAChR numbers such as a decrease in nAChR cell-surface turnover (Peng et al., 1994) , increased nAChR trafficking to the surface (Darsow et al., 2005) been proposed to upregulate without increases in nAChR numbers such as a change in nAChR stoichiometry (Nelson et al., 2003; Moroni et al., 2006 ) and a nicotine-induced conformational change of nAChRs that alters the nAChR ligand binding state and function (Vallejo et al., 2005) . In these studies, a single mechanism was assumed to be the predominant cause of upregulation, and the possibility of multiple mechanisms was not considered. Furthermore, all of the studies were performed on cells heterologously expressing nAChRs because of the difficulties involved in performing radiolabeled ligand-binding measurements and other assays on brain tissue. As a consequence, how these studies relate to the native brain nAChRs in neurons is unclear.
In this study, we characterized the nicotine-induced upregulation of ␣4␤2 nAChRs in cultured cortical neurons by measuring the kinetics of upregulation of native nAChRs in real time and in living brain-derived neurons. During long exposures of the neurons to nicotine (17-24 h), 125 I-epi binding increased at two rates with values of 1.1 and 12.5 h. When nicotine was withdrawn, 125 I-epi binding decayed at different rates, with values of 0.45 h and 12.3 d. That the first process can occur independent of the second was demonstrated with shorter exposures of the cortical neurons to nicotine (Յ4 h) where only the fast decay occurred (Fig. 2C) . During the initial process, nAChR numbers did not change and conformational-dependent binding of a set of nAChR-specific mAbs occurred (Fig. 6D) . Conformationaldependent mAb binding remained only during the rapid decay and was gone subsequently. In addition, 125 I-epi binding to cell-surface nAChRs rapidly dissipated (Fig. 3E) , while the number of cellsurface nAChRs as assayed by immunoblot analysis remained essentially unchanged (Fig. 3D) . Based on these results, we conclude that the initial component of upregulation results from nicotine-induced nAChR conformational changes. We assume that the conformational changes alter 125 I-epi binding because they reflect nAChR transitions from a "resting" state with negligible 125 I-epi binding to an "upregulated state" with high-affinity 125 I-epi binding as previously proposed (Vallejo et al., 2005) .
We also characterized mechanisms responsible for the second component of upregulation. During the onset of this process in HEK cells, we observed increased nAChR assembly (Fig. 4 A) as previously observed (Sallette et al., 2005) . A decreased rate of newly synthesized ␤2 subunit degradation (Fig. 4 A-C) accompanied nicotine-induced increases in nAChR assembly. Blocking proteasome-associated proteases increased subunit levels in cortical neurons and HEK cells (Fig. 5 A, C, left) . The proteasome inhibition also increased 125 I-epi binding in HEK cells and cortical neurons consistent with increases associated with the second component of the upregulation (Fig. 5A, right, C, right) . In addition, the decay rate of the second process in HEK cells ( ϭ 44 h; Fig. 2 D) correlated with the rate of degradation of mature ␣4␤2 nAChRs (mean ϭ 35 h; Fig. 3D ). Altogether, our results are consistent with a series of events starting with a mechanism protecting ␤2 subunits from degradation by proteasomes (Rezvani et al., 2009) . The resultant increased levels of ␤2 subunits increases nAChR assembly in the ER and more intracellular and cellsurface nAChRs accumulate. The mechanisms causing the second component are, thus, distinct from those causing the first component of upregulation and result in significant changes in the number of upregulated ␣4␤2 nAChRs.
Aspects of upregulation, including its dose dependence and its kinetics, depended on the cell type (HEK cell vs cortical neurons) and subunit composition (Table 1) . If the cortical neuron nAChR subunit composition is predominantly ␣4 and ␤2 as indicated by our data (Fig. 1 B, C) , then other factors appear to cause the dif-
